High sTILs also correlated with longer DFS and OS with anthracycline-only, but not anthracycline + taxane ChT, in a group of 297 HER2+ BC patients in BIG 02-98 trial; however, due to lack of anti-HER2 therapy use, these results may not be applicable to current patient populations [32]. The gene discussed is ERBB2; the disease is breast cancer.